Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymph Node-negative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02549677
What this trial is testing

Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer

Who this might be right for
Breast Neoplasms
Ruijin Hospital 294
Large-scale testing (Phase 3)Active Not RecruitingNCT06637150
What this trial is testing

Dalpicilib-Enhanced Vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 1,388
Large-scale testing (Phase 3)Active Not RecruitingNCT00433511
What this trial is testing

Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Who this might be right for
Breast Adenocarcinoma
National Cancer Institute (NCI) 4,994
Early research (Phase 1)Looking for participantsNCT06121557
What this trial is testing

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 24
Not applicableStudy completedNCT06673472
What this trial is testing

Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patients with Node-Negative Gastric Cancer

Who this might be right for
Lymph Node-negativeGastric Cancer
Chang-Ming Huang, Prof. 1,081
Testing effectiveness (Phase 2)UnknownNCT04659499
What this trial is testing

Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer

Who this might be right for
Early Breast Cancer
Peking Union Medical College Hospital 261
Not applicableUnknownNCT04644848
What this trial is testing

Ultrasonographic Axillary Localization

Who this might be right for
Breast Neoplasm
Mansoura University 75
Not applicableActive Not RecruitingNCT03968679
What this trial is testing

Lymph Drainage Mapping for Tailoring Elective Nodal Irradiation in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
The Netherlands Cancer Institute 90
Large-scale testing (Phase 3)Looking for participantsNCT06992882
What this trial is testing

A Randomized, Open-label, Multi-center Phase III Study Comparing the Efficacy of Oral Chemotherapy Combined With Trastuzumab Versus Paclitaxel Combined With Trastuzumab in the Adjuvant Treatment of HER2-positive, Lymph Node-negative Early Breast Cancer Patients(ORCHID-PLUS)

Who this might be right for
HER2-positive Breast Cancer
Fudan University 2,306
Large-scale testing (Phase 3)UnknownNCT02891083
What this trial is testing

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
Shanghai Chest Hospital 486
Not applicableNot Yet RecruitingNCT07573397
What this trial is testing

A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Fudan University 88
Large-scale testing (Phase 3)Study completedNCT00424606
What this trial is testing

Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 658
Testing effectiveness (Phase 2)Active Not RecruitingNCT04443348
What this trial is testing

Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)

Who this might be right for
Triple Negative Breast CancerHormone Receptor Positive (HR+), HER2-negative Breast CancerBiopsy-proven, Positive Lymph Node(s)
Laura M. Spring, MD 120
Large-scale testing (Phase 3)Study completedNCT00433589
What this trial is testing

Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 6,600
Large-scale testing (Phase 3)Study completedNCT00121992
What this trial is testing

Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment

Who this might be right for
Breast Neoplasms
Spanish Breast Cancer Research Group 1,060
Large-scale testing (Phase 3)Not Yet RecruitingNCT07213206
What this trial is testing

CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 1,500
Not applicableStudy completedNCT00593346
What this trial is testing

Evaluation of Accelerated Partial Breast Brachytherapy

Who this might be right for
Breast Cancer
Washington University School of Medicine 151
Not applicableStudy completedNCT02572661
What this trial is testing

Mapping of Sentinel Lymph Node Drainage Using SPECT (SUSPECT) (SUSPECT)

Who this might be right for
Head and Neck Cancer
The Netherlands Cancer Institute 61
Not applicableStudy completedNCT05625698
What this trial is testing

Premarking of Axillary Nodes Before Start of Neoadjuvant Chemotherapy Using Magnetic Approach

Who this might be right for
Breast Cancer
Vastra Gotaland Region 80
Not applicableLooking for participantsNCT07622836
What this trial is testing

A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.

Who this might be right for
TNBCAdjuvant TherapyLymph Node Positive
The First Affiliated Hospital with Nanjing Medical University 59
Next Page